Abstract:ABSTRACT Thymidine analogs, including 3′-azido-3′-deoxythymidine (AZT) and 2′,3′-dideoxy-3′-deoxythymidine (D4T), are important antiretroviral agents. To exert antiretroviral activity, these analogs undergo a stepwise phosphorylation intracellularly to the active triphosphate metabolites. We previously reported that 4′-substituted D4T with an ethynyl group (i.e., 4′-ethynyl D4T) increased the anti-human immunodeficiency virus (HIV) activity and was active against multidrug-resistant HIV strains. 4′-Ethynyl D4T is a better substrate for phosphorylation by human thymidine kinase 1 than D4T is. In this report, we first studied the enzymes involved in the phosphorylation of 4′-ethynyl D4T from monophosphate to triphosphate metabolites. The 4′-ethynyl D4TMP is phosphorylated by recombinant human TMP kinase with a K m of 19 ± 4 μM and a k cat of 0.007 ± 0.001 s −1 ; the relative efficiency is about 9 and 15% of those of D4TMP and AZTMP, respectively. Several enzymes from crude cellular extracts, including nucleoside diphosphate kinase, pyruvate kinase, creatine kinase, and 3-phosphoglycerate kinase, could phosphorylate 4′-ethynyl D4T-diphosphate. The relative phosphorylation efficiencies of 4′-ethynyl D4TDP were about 3 to 25% of those of D4TDP and were generally similar to those of AZTDP. In T-lymphoid cell lines, there was a preponderant accumulation of 4′-ethynyl D4TMP, suggesting that TMP kinase could be the rate-limiting enzyme in the metabolism of 4′-ethynyl D4T. Although the same enzymes are involved in the stepwise phosphorylation of thymidine analogs, their behaviors in phosphorylating metabolites of 4′-ethynyl D4T are different from those of D4T and AZT. Qualitatively, the metabolism of 4′-ethynyl D4T is more similar to that of AZT than to that of its progenitor, D4T.

Antiviral Activity of Lipophilic Nucleoside Tetraphosphate Compounds

Membrane Permeable, Bioreversibly Modified Prodrugs of Nucleoside Diphosphate-γ-Phosphonates

Lipophilic Nucleoside Triphosphate Prodrugs of Anti-HIV Active Nucleoside Analogs as Potential Antiviral Compounds

Prodrugs of Γ‐alkyl‐modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase

Γ‐non‐symmetrically Dimasked TriPPPro Prodrugs As Potential Antiviral Agents Against HIV

Syntheses and characterization of long-chain alkyl nucleoside H-phosphonate derivatives

Synthesis and Metabolism Studies in vitro of d4T-5'-H-phosphonate Prodrugs

Synthesis and spectroscopic analysis of 2′,3′-didehydro- 2′,3′-dideoxythymidine (d4T) 5′-thiophosphoramidates

Synthesis of Alpha-P-modified Nucleoside Diphosphates with Ethylenediamine.

Synthesis of galactosyl phosphate diester derivatives of nucleosides

Synthesis of Aminopropyl Phosphonate Nucleosides with Purine and Pyrimidine Bases

Identification of Amino Acid Phosphorodiamidates of Antiviral Nucleosides Using Electrospray Ionisation Tandem Mass Spectrometry

Comparison of the Phosphorylation of 4′-Ethynyl 2′,3′-Dihydro-3′-deoxythymidine with That of Other Anti-Human Immunodeficiency Virus Thymidine Analogs

Novel Use of a Guanosine Prodrug Approach to Convert 2',3'-Didehydro-2',3'-dideoxyguanosine into a Viable Antiviral Agent.

Synthesis and Anti‐HIV Activity of a Series of 6‐modified 2′,3′‐dideoxyguanosine and 2′,3′‐didehydro‐2′,3′‐dideoxyguanosine Analogs

Synthesis and Antiviral Activities of Isonucleosides and Their Monophosphates

Design, synthesis and biological evaluation of aryloxy thiophosphoramidate triesters of anticancer nucleoside analogues

Synthesis and Properties of α-Phosphate-Modified Nucleoside Triphosphates

Synthesis and Antiviral Evaluation of 3'- C -Hydroxymethyl-3'- O -Phosphonomethyl-β-D-5'-deoxyxylose Nucleosides

The Interactions of Anti-HIV Pronucleotides with a Model Phospholipid Membrane

Synthesis of LAVR-289, a new [(Z)-3-(acetoxymethyl)-4-(2,4-diaminopyrimidin-6-yl)oxy-but-2-enyl]phosphonic acid prodrug with pronounced antiviral activity against DNA viruses